Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment (Q38925157)

7 September 2017

1 reference

title

Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment (English)

1 reference

7 September 2017

Byung-Hak Kim

1

1 reference

7 September 2017

Eun Hee Yi

series ordinal

2

1 reference

7 September 2017

Sang-Kyu Ye

series ordinal

3

1 reference

7 September 2017

language of work or name

1 reference

11 August 2016

1 reference

Archives of Pharmacal Research

7 September 2017

published in

1 reference

7 September 2017

volume

39

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

1085-1099

1 reference

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Therapeutic targeting of the Jak/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT3 as a target for inducing apoptosis in solid and hematological tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The tumour microenvironment as a target for chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The tumor microenvironment at a glance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The role of the tissue microenvironment in the regulation of cancer cell motility and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Targeting JAK kinase in solid tumors: emerging opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT3 Target Genes Relevant to Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

New horizons in tumor microenvironment biology: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Targeting the tumor microenvironment: from understanding pathways to effective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Chronic inflammation and oxidative stress in human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Cancer invasion and the microenvironment: plasticity and reciprocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Strategies and Approaches of Targeting STAT3 for Cancer Treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Targeting protein-protein interactions: suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain binders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Interleukin-6 signaling pathway in targeted therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT3 mutations in the hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inflammation and cancer: an ancient link with novel potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT3 signaling: anticancer strategies and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

T cell exclusion, immune privilege, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Progress towards the development of SH2 domain inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Chronic inflammation and cytokines in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

IL‐6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

HIC1 interacts with and modulates the activity of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inflammation, a key event in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Identification of a New Series of STAT3 Inhibitors by Virtual Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Cancer and the tumor microenvironment: a review of an essential relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Therapeutic modulators of STAT signalling for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

JAKs and STATs in immunity, immunodeficiency, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The JAK-STAT pathway: impact on human disease and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Current status of SRC inhibitors in solid tumor malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Microenvironmental regulation of tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The JAK/STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Stattic: a small-molecule inhibitor of STAT3 activation and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Regulation of gene-activation pathways by PIAS proteins in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Impact of the physical microenvironment on tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STAT family of transcription factors in cytokine-mediated biological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Novel high-throughput screening system for identifying STAT3-SH2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Mechanisms of Jak/STAT signaling in immunity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Migratory neighbors and distant invaders: tumor-associated niche cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Inhibitors of cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Signal Transducer and Activator of Transcription 3 (Stat3C) Promotes Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Lung Tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Dual roles of immune cells and their factors in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

The roles of the Drosophila JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Small molecule inhibitors of STAT3 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-016-0795-8

10.1007/S12272-016-0795-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1036286246

0 references

1 reference